Bull Case

Pricing and mix improve as Kenvue sustains premium household and self-care demand, lifting margins versus consumer-health peers with heavier commodity or discretionary exposure.

Retail execution and shelf-stable demand support modest volume growth, allowing revenue to outpace slower-moving peers such as Haleon and Perrigo in core categories.

Cost savings and supply-chain simplification flow through to operating profit, expanding margins from the current ~19.6% level and narrowing the gap to best-in-class branded peers.

Moderate leverage at 2.3x net debt/EBITDA remains manageable, preserving flexibility for reinvestment and supporting steadier cash conversion than more levered peer models.

Base Case

Core brands remain resilient but mature, producing low-single-digit revenue growth that tracks or slightly exceeds broader consumer-health peers.

Mix and productivity gains offset inflation and promotional pressure, keeping operating margins near current levels rather than materially re-rating upward.

Net debt around 2.3x EBITDA and interest coverage above 7x support continued deleveraging, but not enough to create a large valuation rerating versus stronger-growth peers.

Relative to peers, Kenvue’s forward profile stays defensive and cash-generative, with stability more likely than acceleration in the next 1–3 years.

Bear Case

Private-label and promotional competition intensify, pressuring volumes and forcing price investment that leaves Kenvue growing below peers in key categories.

Input-cost inflation or mix deterioration compresses margins, reversing recent operating leverage and reducing cash generation from the current ~19.6% margin base.

Slower deleveraging keeps net debt elevated relative to peers, limiting strategic flexibility and sustaining a valuation discount versus cleaner balance sheets.

If category demand weakens further, Kenvue’s defensive profile cushions the downside, but it still underperforms more agile peers with stronger innovation or growth momentum.

Overall Score

Kenvue’s most likely path is steady, defensive cash generation with modest growth and stable margins, while the upside case is supported by margin execution and manageable leverage.